Clinical analysis of preventing the progress of chronic serious hepatitis B with Lamivudine during the short-term / 中国实用内科杂志

ABSTRACT

Objective To study the effect of Lamivudine therapy in preventing disease progression in patients with the chronic serious hepatitis B during the short-term. Methods 40 patients with the chronic serious hepatitis B, who have the trend of developing severe hepatitis,were randomized into treating group(n=20) and control group (n=20).The two groups were given the same synthetic treatment. Treating group was given Iamivudine 100mg daily in addition, for 8 weeks. Effects were assessed by clinical , biochemical , the incidence of chronic severe hepatitis,suvival rates and virologic parameters. Results (1) After 8-weeks treatment , the incidence of chronic severe hepatitis in treating group was lower than in control group(X~2=4. S1 ,P